logo of the EU drugs agency

You are viewing archived content

Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.

Table TDI-11 Age at first use and primary drug. EU, Croatia, Norway and Turkey, 2011 or most recent year available

Part (i) Age at first use distribution, New outpatient clients (%)

Substance<1515–1920–2425–2930–3435–3940–4445+Mean ageAge known (base)Age not known
Opiates7.736.227.413.27.83.82.31.623.0378764066
Cocaine6.442.926.611.36.23.32.01.422.3273552794
Stimulants13.654.118.86.93.41.80.70.619.861231699
Hypnotics and sedatives13.924.314.910.49.58.16.312.627.82738772
Hallucinogens12.558.020.94.81.41.40.50.519.341773
Volatile substances60.328.74.61.13.41.10.30.316.334869
Cannabis 43.645.77.81.60.70.30.20.216.6476909352
Other substances 20.036.419.37.96.62.62.74.622.21215382
Total21.942.018.87.84.52.31.41.220.312376219207
 

Notes:

The number of treatment clients in each country is listed in Table TDI-7.

See also Table TDI-106 on distribution by country and '‘General notes for interpreting data'’ on the Explanatory notes and help page.

Source:

Reitox national reports 2012 — Table TDI — outpatient treatment centres.

Page last updated: Friday, 26 April 2013